The estimated Net Worth of Ashley M. Keating is at least 282 千$ dollars as of 14 March 2024. Ms. Keating owns over 500 units of Medpace Inc stock worth over 167,285$ and over the last 6 years she sold MEDP stock worth over 0$. In addition, she makes 114,939$ as Independent Director at Medpace Inc.
Sign up
Ms. Keating MEDP stock SEC Form 4 insiders trading
Ashley has made over 7 trades of the Medpace Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently she exercised 500 units of MEDP stock worth 42,180$ on 14 March 2024.
The largest trade she's ever made was exercising 2,000 units of Medpace Inc stock on 26 October 2021 worth over 109,980$. On average, Ashley trades about 536 units every 73 days since 2019. As of 14 March 2024 she still owns at least 500 units of Medpace Inc stock.
You can see the complete history of Ms. Keating stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ashley Keating biography
Ashley M. Keating serves as Independent Director of the Company since May 17, 2019. Ms. Keating is currently the Chief Financial Officer of CincyTech, one of the most active seed-stage investors in the Midwest focused on providing startup capital and guidance to human health and technology companies primarily in Southwest Ohio. From 2005 to April 2016, Ms. Keating worked at PricewaterhouseCoopers (PwC) where she focused on finance, operations, business leadership and mergers and acquisitions. She began her career in audit services at PwC’s Cincinnati office and later transferred to PwC’s transaction services practice in the New York and London offices. Ms. Keating is a Certified Public Accountant. She received her Bachelor of Business Administration in Accounting and Finance from Ohio University. While at Ohio University Ms. Keating played on the women’s golf team and was named a Division I All-American Scholar. Ms. Keating was chosen as a director because of her experience with biotech funding and her financial and accounting experience.
What is the salary of Ashley Keating?
As the Independent Director of Medpace Inc, the total compensation of Ashley Keating at Medpace Inc is 114,939$. There are 12 executives at Medpace Inc getting paid more, with August Troendle having the highest compensation of 7,712,840$.
How old is Ashley Keating?
Ashley Keating is 38, she's been the Independent Director of Medpace Inc since 2019. There are 14 older and no younger executives at Medpace Inc. The oldest executive at Medpace Holdings Inc is Fred Davenport, 68, who is the Lead Independent Director.
What's Ashley Keating's mailing address?
Ashley's mailing address filed with the SEC is C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI, OH, 45227.
Insiders trading at Medpace Inc
Over the last 8 years, insiders at Medpace Inc have traded over 3,140,136,825$ worth of Medpace Inc stock and bought 2,899,276 units worth 330,034,155$ . The most active insiders traders include Limited Partnership Medpace...、August J. Troendle、Investors, Llc Medpace. On average, Medpace Inc executives and independent directors trade stock every 9 days with the average trade being worth of 40,224,347$. The most recent stock trade was executed by Robert O. Kraft on 22 August 2024, trading 8,127 units of MEDP stock currently worth 346,373$.
What does Medpace Inc do?
a therapeutically focused leader in research-based drug development, medpace builds strong strategic partnerships with select sponsors to advance the most efficient and cost-effective path to drug approval. as a full service, global clinical research organization (cro), medpace sees itself as a steward of your drug, leveraging its extensive medical and regulatory expertise to deliver additional input, strategy, and efficiencies to each and every phase of the clinical trial. from custom solutions addressing the needs of small and midsize biotechnology companies to full-service offerings for global pharmaceutical companies, medpace has the breadth, depth, and flexibility to deliver a superior result, specific to your needs, on six continents.
What does Medpace Inc's logo look like?
Complete history of Ms. Keating stock trades at Medpace Inc
Medpace Inc executives and stock owners
Medpace Inc executives and other stock owners filed with the SEC include:
-
August Troendle,
Chairman of the Board, President, Chief Executive Officer -
Susan Burwig,
Executive Vice President - Operations -
Jesse Geiger,
Chief Financial Officer, Chief Operating Officer - Laboratory Operations -
Stephen Ewald,
General Counsel, Corporate Secretary -
Dr. August James Troendle M.D.,
Chairman & CEO -
Susan E. Burwig,
Exec. VP of Operations -
Jesse J. Geiger BBA, CPA,
Pres -
Stephen P. Ewald,
Chief Compliance Officer, Gen. Counsel & Corp. Sec. -
Brian Carley,
Independent Director -
Robert Kraft,
Independent Director -
Fred Davenport,
Lead Independent Director -
Cornelius McCarthy,
Independent Director -
Ashley Keating,
Independent Director -
Thomas King,
Independent Director -
Brandon Ebken,
Chief Information Officer -
John T. Wynne,
Sr. VP of Commercial Operations & Clinical Pharmacology Unit -
Daniel O'Leary,
Sr. VP of Medical Department -
Weimin Gai MS,
Sr. VP of Biometrics -
Todd Meyers,
VP of Bus. Devel. & Marketing -
Lauren Morris,
Associate Director of Investors Relations -
Kevin M. Brady,
CFO & Treasurer -
Penelope J Bucknell,
VP, Human Resources -
Bruce Brown,
Director -
Cinven Fund (No. 1) Limited...,
-
Limited Partnership Medpace...,
-
Dani S. Zander,
Director -
Investors, Llc Medpace,
10% owner -
Tom C King,
Director -
Kevin M. Brady,
CFO & Treasurer